Aperam


FY23 in line; some hopes for recovery (H2 24)?

12/02/24 -"The group released an expected set of results, while it also anticipates a rather similar Q1 24 vs Q3 23. Even if the market is still depressed, particularly in Europe, a stabilisation is welcome and ..."

Pages
72
Language
English
Published on
12/02/24
You may also be interested by these reports :
02/09/26
Boliden had a very strong run over past month. This has been an interesting revival of sentiment as market reaction to the firm’s Q2 results was ...

31/08/26
Finally, Nornickel is delivering to its potential – with very strong H1 results also resulting in dividend reinstatement. While strong prices were a ...

27/08/26
FY26 was strong for South32, with valuable contributions from Aluminium and Zinc being well complemented by various positives in Copper and ...

18/08/26
World’s largest miner i.e. BHP reported strong FY26 results, which also resulted in highest dividend being announced in four years. Copper was the ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO